Evidence map›Paper›PMID 42333755›Full record

ArticleEpidemiology and infection2026

Mpox seroprevalence among sex workers and men who have sex with men preceding sustained urban outbreak in the Democratic Republic of the Congo.

Patrick K Mukadi, Sydney Merritt, Antoine Nkuba-Ndaye, Megan Halbrook, Yvon Anta, Tavia Bodisa Matamu, Emmanuel Hasivirwe Vakaniaki, Daniel Mukadi-Bamuleka, Ryan J Harrigan, Lygie Lunyanga and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Epidemiology and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Patrick K MukadiEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Sydney MerrittEpidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Publi, Los Angeles, USA.ORCID 0000-0002-4039-605X
Antoine Nkuba-NdayeService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Universite de Kinshasa Faculte de Medecine, Kinshasa, Congo, The Democratic Republic of the.
Megan HalbrookEpidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Publi, Los Angeles, USA.
Yvon AntaEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Tavia Bodisa MatamuRodolphe Merieux Institut National de Recherche Biomedicale (INRB) Laboratory, Goma, Congo, The Democratic Republic of the.
Emmanuel Hasivirwe VakaniakiEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Daniel Mukadi-BamulekaService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Universite de Kinshasa Faculte de Medecine, Kinshasa, Congo, The Democratic Republic of the.
Ryan J HarriganCenter for Tropical Research, UCLA Institute of the Environment and Sustainability, University of California Los Angeles, Los Angeles, USA.
Lygie LunyangaEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Cris KacitaNational Program for the Control of Mpox and Viral Hemorrhagic Fevers, Government of the Democratic Republic of the Congo Ministry of Health, Kinshasa, Congo, The Democratic Republic of the.
Jean Paul KompanyEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Sylvie LinsukeEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Candice LemailleMedical Microbiology & Infectious Diseases, University of Manitoba Max Rady College of Medicine, Winnipeg, Canada.
Marie Clotilde InakaNational Program for HIV/AIDS, Ministry of Health, Kinshasa, Kinshasa, Democratic Republic of the Congo.
Ahidjo AyoubaTransVIHMI, Universite de Montpellier, INSERM, Institut pour le Recherche et Developpement (IRD), Montpellier, France.
Nicole A HoffEpidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Publi, Los Angeles, USA.
Jason KindrachukMedical Microbiology & Infectious Diseases, University of Manitoba Max Rady College of Medicine, Winnipeg, Canada.
Lisa E HensleyZoonotic and Emerging Disease Research Unit (ZEDRU), United States Department of Agriculture, Agriculture Research Services (USDA-ARS), Manhattan, USA.
Martine PeetersTransVIHMI, Universite de Montpellier, INSERM, Institut pour le Recherche et Developpement (IRD), Montpellier, France.
Placide Mbala-KingebeniEpidemiology and Global Health, Institut National de Recherche Biomédicale, Congo, The Democratic Republic of the.
Steve Ahuka-MundekeService de Microbiologie, Département de Biologie Médicale, Cliniques Universitaires de Kinshasa, Universite de Kinshasa Faculte de Medecine, Kinshasa, Congo, The Democratic Republic of the.
Anne W RimoinEpidemiology, University of California Los Angeles Jonathan and Karin Fielding School of Publi, Los Angeles, USA.

Funding

Agence Nationale de Recherches sur le Sida et les Hépatites Virales PANAFPOXAgricultural Research Service 58-3022-2-020CIHR MRR-184813
6 · The paper itself

Abstract

Mpox has evolved into a global public health concern following rapid geographic expansion and altered clinical and epidemiological characteristics. The 2022 outbreak of monkeypox virus (MPXV) marked the first widespread expansion to non-endemic regions, particularly among men who have sex with men (MSM). In the Democratic Republic of the Congo (DRC), where Clade I MPXV is endemic, data on urban exposures are limited. We evaluated serologic evidence of exposure using a four-plex MPXV assay among 1,823 participants from two major DRC cities, Kinshasa and Goma, between April and June 2024. Of these participants, 523 (28.7%) self-identified as MSM, 498 (27.3%) as professional sex workers (SW), 107 (5.9%) as MSM and SW, and 695 (38.1%) as other at-risk individuals. Overall, 2.9% of participants were seroreactive. By subpopulation, 4.8%, 2.1%, and 1.7% of at-risk, MSM, and SW participants were seroreactive (

Indexed as

Disease OutbreaksHomosexuality, MaleMpox, MonkeypoxSex WorkersAdolescentAdultDemocratic Republic of the CongoHumansMaleMiddle AgedSeroepidemiologic StudiesUrban PopulationYoung AdultDR Congohigh risk populationsMpoxMPXV Clade Iseroprevalenceurban centres

Identifiers

PMID42333755
PMCPMC13459010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.